Chr. Olesen Synthesis Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 78

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

  • Investments
  • 1

Chr. Olesen Synthesis General Information

Description

Manufacturer of active pharmaceutical ingredients designed for the pharmaceutical industry. The company's technology utilizes synthetic chemistry and cgmp-certified manufacturing processes to produce controlled substances and advanced intermediates, providing pharmaceutical companies with essential components for medications treating opioid use disorder.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Kanalholmen 8-12
  • 2650 Hvidovre
  • Denmark
+45 36
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Specialty Chemicals
Corporate Office
  • Kanalholmen 8-12
  • 2650 Hvidovre
  • Denmark
+45 36

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chr. Olesen Synthesis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chr. Olesen Synthesis‘s full profile, request access.

Request a free trial

Chr. Olesen Synthesis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chr. Olesen Synthesis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Chr. Olesen Synthesis‘s full profile, request access.

Request a free trial

Chr. Olesen Synthesis Investments (1)

Chr. Olesen Synthesis’s most recent deal was a Later Stage VC with CCURE. The deal was made on 01-Jan-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CCURE 01-Jan-2011 Later Stage VC Distributors (Healthcare)
To view Chr. Olesen Synthesis’s complete investments history, request access »

Chr. Olesen Synthesis Exits (1)

Chr. Olesen Synthesis’s most recent exit was on 01-Jan-2011 from CCURE. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
CCURE 01-Jan-2011 Completed
  • 2 buyers
To view Chr. Olesen Synthesis’s complete exits history, request access »

Chr. Olesen Synthesis FAQs

  • When was Chr. Olesen Synthesis founded?

    Chr. Olesen Synthesis was founded in 2011.

  • Where is Chr. Olesen Synthesis headquartered?

    Chr. Olesen Synthesis is headquartered in Hvidovre, Denmark.

  • What is the size of Chr. Olesen Synthesis?

    Chr. Olesen Synthesis has 78 total employees.

  • What industry is Chr. Olesen Synthesis in?

    Chr. Olesen Synthesis’s primary industry is Pharmaceuticals.

  • Is Chr. Olesen Synthesis a private or public company?

    Chr. Olesen Synthesis is a Private company.

  • What is Chr. Olesen Synthesis’s current revenue?

    The current revenue for Chr. Olesen Synthesis is .

  • How much funding has Chr. Olesen Synthesis raised over time?

    Chr. Olesen Synthesis has raised $11.2M.

  • Who are Chr. Olesen Synthesis’s investors?

    Samfara and ACE & Company (Geneva) have invested in Chr. Olesen Synthesis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process